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Department of Physiology and Biophysics, State University of New York, Buffalo, New YorkABSTRACT Nicotinic acetylcholine receptors (AChRs) are synaptic ion channels that spontaneously isomerize (i.e., gate)
between resting and active conformations. We used single-molecule electrophysiology to measure the temperature dependen-
cies of mouse neuromuscular AChR gating rate and equilibrium constants. From these we estimated free energy, enthalpy, and
entropy changes caused by mutations of amino acids located between the transmitter binding sites and the middle of the
membrane domain. The range of equilibrium enthalpy change (13.4 kcal/mol) was larger than for free energy change
(5.5 kcal/mol at 25C). For two residues, the slope of the rate-equilibrium free energy relationship (F) was approximately
constant with temperature. Mutant cycle analysis showed that both free energies and enthalpies are additive for energetically
independent mutations. We hypothesize that changes in energy associated with changes in structure mainly occur close to
the site of the mutation, and, hence, that it is possible to make a residue-by-residue map of heat exchange in the AChR gating
isomerization. The structural correlates of enthalpy changes are discussed for 12 different mutations in the protein.INTRODUCTIONThe acetylcholine receptor-channel (AChR) is an ion
channel that uses energy derived from ligand binding to
promote a global change in structure. Without agonists,
the wild-type (wt) neuromuscular AChR almost always
adopts a resting conformation (R) in which the ion channel
is closed and cannot conduct ions. However, when acetyl-
choline (ACh) molecules occupy the two transmitter
binding sites, the protein transiently adopts an active, ion-
conducting conformation (R*) with a high probability.
We, and others, are working to understand the differences
in structure and energy that distinguish R from R* and
that define the mechanism of the R4R* gating
isomerization.
The driving force for the agonist-induced increase in the
gating equilibrium constant is the tighter binding of ACh to
the R* conformation of the protein (1,2). The degree to
which a ligand activates an allosteric protein depends on
both the gating equilibrium constant in the absence of
agonists (E0) and the ratio of equilibrium dissociation
constants, resting/active. Mutations of residues in many
different regions of the AChR, some of which cause congen-
ital myasthenic syndromes (3), change agonist-induced
responses by changing only E0 (4,5). The logarithm of this
constant is proportional to the free energy difference
between the end states (R and R*). Energy and structure
are related, so a mutation that changes E0 must cause a
strain, movement, or change in dynamics, somewhere in
the system.
Free energy is comprised of enthalpy and entropy compo-
nents (6). To a first approximation, enthalpy reflects bonds
and entropy reflects water structure and dynamics. TheSubmitted October 13, 2010, and accepted for publication December 29,
2010.
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0006-3495/11/02/0904/8 $2.00enthalpy change, R-to-R*, is manifest experimentally as
the temperature dependence of the gating equilibrium
constant. This is a measure of the heat absorbed (or emitted)
in the isomerization. A mutation that changes the amount of
heat exchanged with the bath will change the temperature
dependence of the gating equilibrium constant.
The adult neuromuscular AChR consists of five subunits
(a2bd3) arranged symmetrically around a central ion perme-
ation pathway (7). In each subunit the extracellular,
N-terminal half is mostly b-sheet with connecting loops
and the transmembrane portion is a four a-helix bundle.
The five sets of b-barrels comprise the extracellular domain
(ECD) and the five sets of helix bundles form the transmem-
brane domain (TMD). The two transmitter binding sites
are located in the ECD and the gate region of the channel
may be near the equator of the TMD. Several relevant
structures are available (8–14), but as yet there is no clear
understanding of the structural differences between R and
R*(15).
We have used single-channel electrophysiology to
measure gating rate and equilibrium constants and to esti-
mate the free energy, enthalpy, and entropy changes associ-
ated with different AChR mutations. Our objective was to
relate these quantities to possible underlying structural
changes caused by the mutations. We hypothesize that the
energy changes are dissipated near the site of the mutation,
and, hence, that the enthalpy measurements constitute
a thermal map of AChR gating.MATERIALS AND METHODS
Detailed methods can be found elsewhere (16). HEK 293 cells plated on
polylysine-coated glass coverslips were transiently transfected with wild-
type and mutant mouse AChR subunit DNA using calcium phosphate
precipitation (a, b, d, and 3; 1.8 mg total DNA in the ratio 2:1:1:1). The
culture medium was changed after 16 h and electrophysiological recordings
commenced 18–24 h later. Mutations were made using the QuikChangedoi: 10.1016/j.bpj.2010.12.3739
FIGURE 1 Locations of the mutations. The unliganded Torpedo AChR
(accession number 2bg9.pdb) Only the ad-and d-subunits are displayed;
horizontal lines mark approximately the membrane. aW149 is at a trans-
mitter binding site. The four transmembrane helices are labeled M1–M4
in the d-subunit. The mutated residues are dark gray.
Temperature and AChR Mutants 905Mutagenesis Kit (Stratagene, La Jolla, CA) and confirmed by dideoxy
sequencing. Single-channel recordings were from cell-attached patches.
Rate constants at a given temperature were estimated for each construct
from several patches obtained on different days and from different culture
dishes. The pipette potential was þ80 mV, which corresponds to
a membrane potential of ~100 mV. The bath and pipette solutions were
Dulbecco’s phosphate-buffered saline containing: 137 mM NaCl, 0.9 mM
CaCl2, 2.7 mM KCl, 1.5 mM KH2PO4, 0.5 mM MgCl2, and 8.1 mM
Na2HPO4 (pH 7.4). Currents were low-pass-filtered at 20 kHz and digitized
at a sampling frequency of 50 kHz. Agonists were added only to the pipette
solution. Kinetic analyses were carried out by using QUB software (www.
qub.buffalo.edu). At high-agonist concentrations channel openings
occurred in clusters that represent both binding and R4R* gating of indi-
vidual AChRs.
Without an external energy source, the ratio of the diliganded/unliganded
gating equilibrium constants (E2/E0) is equal to the ratio of the agonist equi-
librium dissociation constants in R versus R* (l ¼ Kd/Jd) squared. Hence,
E2¼ E0l2. In some experiments, we measured E0 directly (no added agonist
molecules) and in others we measured E2 (with agonists). The mutations
studied with agonists were not at the transmitter binding sites. We assumed
that the mutations did not affect l but changed E2 by an equivalent change
in E0 (4,5).
The activation enthalpy (Ea, in kcal/mol) was estimated by using the
Arrhenius equation
lnðkÞ ¼ lnðAÞ  Ea=RT; (1)
where k is the experimentally determined rate constant, A* is the prefactor,
and R is the gas constant (1.987 cal/K/mol) at temperature T (K). Ea is an
approximation of the enthalpy of the transition state relative to either the
R (Ea
f) or R* (Ea
b) end state. The equilibrium enthalpy (DH) and entropy
(DS) changes associated with R4R* gating were quantified by using the
van ’t Hoff equation
ln

Keq
 ¼  DH=RT þ DS=R; (2)
where Keq is an equilibrium constant (either E0 or E2). Each point in the
Arrhenius and van ’t Hoff plots is the average obtained from at least three
different patches. The Gibbs free energy change (DG) at a given tempera-
ture was calculated from the van ’t Hoff plot as
DG ¼ DH  TDS: (3)
The value V was estimated as the linear slope of a rate-equilibrium rela-
tionship which is a log-log plot of the forward, channel-opening rate
constant (f2) versus E2 for a family of mutations of a single position in
the protein. Each point in the plot has been normalized to the background
value and represents the mean of at least three patches for each mutant
construct.RESULTS
We investigated the temperature dependence of gating rate
and equilibrium constants for neuromuscular AChRs having
mutations in different regions of the protein (Fig. 1 and
Table S1 in the Supporting Material). For each mutation,
the van ’t Hoff plot is shown in Fig. 2 (Table S3) and the
Arrhenius plots are shown in Fig. S2 (Table S2). For tech-
nical reasons, different background constructs and agonists
were used to investigate different mutants. The net change in
relative free energy (DDG at 25C) or enthalpy (DDH)
caused by the mutation was calculated in reference to the
salient background. These results are summarized in Table 1
and later in Fig. 5.Transmitter binding site
The two AChR transmitter binding sites are in the extracel-
lular domain of the a-subunit, at an interface with either the
3- or d-subunit. aW149 is an important binding site amino
acid that influences the resting equilibrium dissociation
constant (Kd), the R/R* affinity ratio (l), and the unliganded
gating equilibrium constant (E0) (17,19).To study mutations
of this residue we used AChRs with background mutations
that increased E0 and, hence, the probability of observing
spontaneous openings in the absence of agonists. Because
we did not add ACh to promote gating of these constructs
we could ignore the large reduction in Kd caused by the
mutations. The R and R* end states and the conformational
pathway(s) connecting them are approximately the same in
these spontaneously-active AChRs and in wild-type (wt)
AChRs activated by agonists (5).
One spontaneously-opening background construct was
aD97AþaY127FþaS269I (DYS). In another, the aS269I
substitution was replaced with aP272A. The third spontane-
ously-opening construct was the double mutant
aA96YþdV269C, which had a total of only three side-chain
substitutions. All of these backgrounds increased substan-
tially E0 and gave rise to AChRs showing a temperature-
dependence in open probability within clusters (Fig. 2 A).Biophysical Journal 100(4) 904–911
FIGURE 2 Temperature dependence of the gating equilibrium constant.
The van ’t Hoff plots are shown for 15 mutant AChRs (Table S3). (A) No
agonist present (unliganded gating); aDYP is aD97AþaY127FþaP272A;
DYS is aD97AþaY127FþaS269I. (B) Unliganded gating of aW149
mutants expressed on the DYS background (example currents, Fig. S3).
(C) Mutants expressed on the wt background and activated by agonists.
aG153S was activated by Cho, and the others were activated by ACh.
aP272G and aG153S are heat-activated and the aY127 mutants are cold-
activated. (D) Unliganded gating of dV269 mutants expressed on the
DYS background.
906 Gupta and AuerbachHowever, it was not possible to calculate DDH values for
these backgrounds because we do not know the temperature
dependence of E0 in wt AChRs.TABLE 1 Normalized thermodynamic parameters determined
from van ’t Hoff plots
Mutant
DDH
(kcal/mol)
TDDS
(kcal/mol)
DDG (25C)
(kcal/mol)
aW149F* þ6.8 þ7.3 0.5
aW149N* þ7.4 þ7.9 0.5
aW149A* 0.3 þ0.9 1.2
aW149R* þ1.6 þ3.6 2.0
aW149T* 0.9 þ0.6 1.5
aG153S þ0.2 þ1.8 1.6
aY127E 3.9 5.3 þ1.4
aY127C 4.9 6.6 þ1.7
aP272G þ2.8 þ1.4 þ1.4
dV269L* þ0.4 þ1.5 1.1
dV269C* þ4.4 þ6.6 2.2
dV269A* 6.0 2.2 3.8
DDH, calculated change in enthalpy change with respect to background
[¼ DHmut–DHbkgd]. TDDS, calculated change in entropy change (T ¼
25C) with respect to background [¼ DSmut–DSbkgd]. DDG, calculated
change in free energy change relative to background [¼ DGmut–DGbkgd].
See Table S3 for the experimental conditions and unnormalized parameters
for each construct, and Fig. 5 for a graphical display of DDH and DDG
(25C).
*Expressed on the DYS background (all others, wt).
Biophysical Journal 100(4) 904–911We recorded spontaneous, single-channel currents and
measured the temperature dependence of E0 for five different
aW149 mutations expressed on the DYS background
(Fig. S3). All of the aW149 mutations modestly increased
E0 at 25
C to similar extents. The range of DDG values was
only ~1.5 kcal/mol (Arg to Phe). However, the range of
DDH values was much larger, with Thr and Asn mutations
of aW149 showing the most extreme enthalpy changes. Rela-
tive to the DYS background, aW149T caused E0 to increase
with lower temperature (cold-activated; R-to-R* emits heat)
and aW149N caused E0 to increase with higher temperature
(heat-activated, R-to-R* absorbs heat). The net enthalpy
change associated with a Thr to Asn substitution was
8.3 kcal/mol. The range of DDG values was smaller than
DDH values, because for each mutation the enthalpy change
was compensated bya change in entropyof similarmagnitude.
The slope of the rate-equilibrium relationship (F) is
a fraction between 1 and 0 that gives the extent to which
a change in equilibrium constant caused by a mutation arises
from a change in the forward-versus-backward rate
constant. Mutations that mainly alter the forward rate
constant have F-values closer to 1. The F-value for the un-
liganded aW149 mutant series at 20C was 0.86 (Fig. 3 A),
indicating that the forward rate constant was mainly altered.FIGURE 3 Rate-equilibrium analyses. (A and B) Log-log plots of
opening rate constant (f0) versus gating equilibrium constant (E0) for fami-
lies of mutations of a single residue (aW149 or dV269), at different temper-
atures (no agonist present). The slope (5SD) of the linear fit,F, is shown at
the bottom right of each panel. (C) For both amino-acid positions, F is
approximately independent of temperature. (D) Enthalpy rate-equilibrium
plots for aW149 and dV269. The y axis is the change in the activation
enthalpy of the opening (forward) rate constant (DEa
f) and the x axis is
the change in enthalpy difference between the ground states (DDH) for
a family of mutations at a single position. For these two positions the slope
of this relationship was the same as F.
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associated with this residue occurs relatively early in the
gating process (18). Fig. 3 C shows that FaW149 did not
change significantly with temperature.
We measured the change in activation enthalpy associated
with the forward and backward isomerization rate constants
(DEa
f and DEa
b) for all of the aW149 mutants (Fig. S2 and
Table S2). DEa
f approximates the net transition state
enthalpy change (relative to the R ground state) caused by
the mutation. Fig. 3 D shows a plot of DEa
f versus DDH
for the aW149 family of mutants. The slope of this plot,
which we call an enthalpy rate-equilibrium relationship,
was the same as for the standard free energy rate-equilib-
rium relationship. This suggests that the enthalpy and free
energy changes occur approximately at the same relative
point in the gating process.
aG153 is in loop B and close to the binding site. Muta-
tions of this amino acid increase E0 and reduce Kd but do
not substantially alter l (19). We studied the congenital
myasthenic mutation aG153S using the wt AChR back-
ground and choline as the activating agonist. This mutation
had only a small effect on the equilibrium gating enthalpy
change. However, this mutation increased both DEa
f and
DEa
b (Table S2).Between the binding site and the TMD equator
aY127 is a residue that is in a pathway that appears to link
gating conformational changes at the binding sites with
those in the membrane domain (20). Mutations of this amino
acid change E0 substantially without affecting Kd or l (21)
Fig. S1 shows ACh-activated, single-channel currents and
interval duration histograms at different temperatures for
aY127E. At 25C, the Glu and Cys substitutions decreased
E2 (presumably only by changing E0) to similar extents, on
average by ~15-fold. Both mutations also showed substan-
tial, negative enthalpy changes (caused the AChR to become
cold-activated). On average, the enthalpy change caused by
these two mutations was DDH¼4.4 kcal/mol. The aY127
mutations were unique among the ones we examined
because a negative enthalpy change was mostly compen-
sated by a large and unfavorable (for the formation of R*)
change in entropy.
aP272 (in the M2-M3 linker) is at the interface between
the ECD and TMD. This amino acid has been proposed to
be the switch that, by a cis-trans isomerization, intercon-
verts the R and R* conformations of the 5HT3A receptor-
channel (22). In AChRs, this residue is probably not such
a defining switch, but mutations here do produce large
changes in the R-versus-R* free energy, approximately
midway through the gating process (23). We studied the
temperature dependence of aP272G using ACh and the wt
background. This mutation reduced E2 by ~11-fold at
25C, and also increased the temperature dependence of
gating (made the AChR more heat-activated than the wt).We also measured DEa
b for additional mutations of
aP272 and other residues between the binding sites and
the middle of the TMD. DEa
b approximates the transition
state enthalpy change (relative to R*) caused by the muta-
tion. The background construct for all of these was wt,
and we normalized the values according to the agonist used
to activate the protein. The results are given in Table S2. At
aP272, Ser and Ala mutations caused a large (>5 kcal/mol)
increase in the DEa
b, but the effect of a Gly substitution
was much smaller.
aP265 is in the N-terminal cap of the pore-lining, M2
transmembrane helix. This amino acid experiences a large
energy change in gating and is interesting because unlike
many other M2 residues, its energy change occurs at the
onset of the channel-opening process (24). DEa
b values for
the three aP265 mutations we studied (Gly, Ser, and Ala)
were similar (~2 kcal/mol) and smaller than for the Ser
and Ala mutations of aP272. Thus, the patterns of DEa
b
were different for mutations of these two prolines.
aE45 (in loop 2 of the extracellular domain) mutations
have a large influence on E2 (21). It has been proposed
that the disruption of a salt bridge involving aE45 and
aR209 is an important event in AChR gating (25), but
some evidence argues against this hypothesis (26,27). We
found that Leu and Arg mutations of aE45 increase DEa
b,
but only modestly (<2 kcal/mol, on average).
aC418 is a lipid-facing residue in the middle of the M4
transmembrane helix. A Trp mutation of this amino acid
increases E2 by ~115-fold at 23
C (28). We found that
DEa
b for this substitution (with choline as the agonist) was
substantial (þ3.6 kcal/mol).The equatorial region of the pore
The equatorial residues of the pore-lining, M2 helix (in
particular, positions 90, 120, and 130) experience large and
late energy changes in the gating isomerization (29–31). It
is possible that this region forms part of a gate that regulates
whether ions pass rapidly through the pore. We investigated
the temperature dependence of E0 for mutations of one
residue here, dV269 (M2–130). Leu, Cys, and Ala substitu-
tions all increasedE0 substantially, which is to say the relative
stability of R*. The temperature experiments, however, re-
vealed very different enthalpy contributions for these three
side chains. Cys increased and Ala decreased enthalpy
substantially (DDH¼þ4.4 and6.0 kcal/mol, respectively),
but the Leu substitution was of little consequence in this re-
gard. As was the case for aW149, F was temperature-inde-
pendent for dV269 and the slopes of the enthalpy and free
energy rate equilibrium plotswere the same (Fig. 3,C andD).
dL265 (M2–90) is located in the gate region and may be in
contact with water molecules in the open pore. DEa
b for the
polar Thr substitution here was large (þ3.4 kcal/mol), indi-
cating that this mutation substantially increased the enthalpy
for channel-closing. In contrast, DEa
b values for all threeBiophysical Journal 100(4) 904–911
908 Gupta and AuerbachdV269 mutations were negative, indicating that these
decreased enthalpy. The largest net transition state enthalpy
changes were for the dV269L and dV269C mutations
(5.6 kcal/mol).An enthalpy mutant cycle analysis
Mutant cycle analysis is a method to probe the extent of free
energy coupling between residues (32). If the sum of the
free energy changes for each of two mutations measured
separately is equal to that for the double mutant, then the
free energy changes of the two residues can be considered
to occur independently of each other. We applied this
same logic to enthalpy changes (Fig. 4).
From the fold-changes inE0 at 25
C, we estimated that the
DDGo [¼ 0.59 ln (E0mutant/E0DYS)] values for aW149F
and dV269L separately were 0.5 and 1.1 kcal/mol,
respectively. We measured a DDGo value of 2.2 kcal/mol
for the double mutant combination, aW149FþdV269L.
Thus, these two distant residues show only a small degree
of free energy coupling (~0.6 kcal/mol). Having already
measured DH separately for these individual mutations,
we next measured DH for the double mutant combination.
Fig. 4 B (Table S3) shows that the sum of the enthalpies
assuming independence (5.0–1.4 ¼ 3.6 kcal/mol) was
approximately the same as the value measured experimen-
tally for the mutant pair (3.25 0.6 kcal/mol). We conclude
that both the gating free energy and enthalpy changes at
these two amino acids are approximately independent.FIGURE 4 Enthalpy mutant-cycle analysis. (A) Example clusters from
aDYS and aW149F, dV269L and the double-mutant aW149FþdV269L
expressed on the aDYS background (no agonist present; 25C). (B) (Solid
circles and solid line) The van ’t Hoff plot for the aW149FþdV269L
construct. (Dashed lines) Single mutant constructs. The change in enthalpy
for the double mutant (DH ¼þ3.2 kcal/mol) is approximately equal to the
sum of the individual enthalpy changes for the single-mutant construct
(þ5.0 kcal/mol for aW149F and 1.5 kcal/mol for dV269L).
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DDG values for gating (at 25C) have been estimated for
thousands of mutations of hundreds of different AChR resi-
dues (33). When mapped onto structure, these values show
that free energy changes are widespread in the protein but
appear to be concentrated mainly 1), in the ECD along the
a/3 and a/d subunit interfaces; 2), at the a-subunit ECD/
TMD interface; and 3), at the equator of M2 in the TMD.
Here we have added another dimension to this map by
measuring the enthalpy component of the free energy change.
The DDH and DDG values for 12 mutations of five resi-
dues are shown in Fig. 5 A. Enthalpy measurements provide
information about gating that cannot be derived from equi-
librium constant measurements at one temperature. The
range of DDH values exceeds that for DDG values. The
difference between the most positive and most negative
enthalpy was 13.4 kcal/mol (aW149N and dV269A),
whereas this range was only 5.5 kcal/mol for free energy
(aY127C and dV269A). The DDG range is smaller because
the free energy change is the difference between compen-
sating enthalpy and entropy changes. It is easier to make
point mutations that change the temperature dependence
of the gating equilibrium constant than the equilibrium
constant itself. For example, aW149F hardly changed the
gating equilibrium constant at 25C but had a large effect
on the temperature dependence of gating.
Mutations of a single residue can make the gating equilib-
rium constant increase/decrease with temperature. Exam-
ples are aW149N/T (at the binding site) and dV269C/AFIGURE 5 Summary of thermodynamic parameters for mutant AChRs.
(A) Mutation-induced changes in enthalpy (DDH; black) and free energy
(DDG; white) relative to the background construct (Table 1). The range
of values for DDH is greater than for DDG because of compensating
entropy changes. (B) A map of enthalpy changes in AChR gating.
aW149F and aP272G are heat-activated (DDH>þ2 kcal/mol);
aY127C and dV269A are cold-activated (DDH<2 kcal/mol); aG153S,
1<DDH<1 kcal/mol. Not shown, mutations of aW149 and dV269 could
result in either positive or negative DDH values.
Temperature and AChR Mutants 909(at the M2 equator). Point mutations of different residues,
too, caused the R-to-R* isomerization to either absorb
(aW149N and aP272G) or emit heat (aY127C and
aV269A). An enthalpy mutant cycle analysis showed that
DDH values for individual mutations can add when the
amino acids are not coupled energetically. This means that
it may be possible to engineer AChRs that have an even
wider range of temperature sensitivities by combining
multiple mutations. Although we have generated spontane-
ously-active AChRs that respond modestly to either heat or
cold, we doubt that it will be possible to achieve the extreme
temperature sensitivities of TRP channels (>100 kcal/mol
(34)) simply by adding a few point mutations.
We now discuss possible structural correlates of the
enthalpy measurements. Each energy measurement applies
to the whole system under investigation, which includes (at
least) the protein, agonist molecules, membrane, water, and
ions. We therefore must consider the issue of whether free
energy, enthalpy, and entropy changes caused by different
agonists or side-chain substitutions are associated with struc-
tural changes that occur in the vicinity of the perturbation or
at some distance. We will refer to these alternatives as local
versus nonlocal. Examples of local structural changes that
may correlate with an enthalpy change include steric bump-
ing, the disruption of a salt bridge or a strain in a bond, all
close to the site of the mutation. Nonlocal structural changes
may occur by a rigid body motion or by a change in normal
modes.We can use the local/nonlocal distinction even though
we do not know precisely the distance that defines each scale,
which indeed may not be the same for different proteins or
different regions within a protein. However, for the purpose
of this discussion we define ‘‘local’’ as within approximately
a side-chain radius of the perturbation.
There is experimental evidence that suggests that the
principle energetic consequence of a mutation is often local.
First, free energy mutant-cycle analyses show that in most
cases the consequences of multiple mutations are approxi-
mately independent. In our lab, we have measured free
energy coupling for >50 different mutant AChR combina-
tions (4,17,20,21,23,27,31,35,36). Only two of these
showed coupling >1 kcal/mol, and these amino acids
were immediate neighbors (20). Also in AChRs, Lee et al.
(37) reported larger coupling energies for 10 of 16 mutant
combinations, but we suspect that many of these were over-
estimated because the equilibrium constants for the single,
gain-of-function mutation aP272A was underestimated
(4). Although it is possible that for each separate AChR
mutation the change in free energy was dissipated
nonlocally, it is difficult to imagine a mechanism by which
these energy consequences would be independent of each
other, given the widespread locations of the mutated resi-
dues in different domains of the protein.
Second, and along similar lines, many different mutations
in the AChR change the gating equilibrium constant without
affecting Kd or the channel conductance. Mutations that areimmediately at the transmitter binding sites or the narrow
region of the pore are exceptions, so these two regions
indeed can be perturbed. As far as we know, in only three
reports a mutation far from the binding site has been
proposed to cause a significant change in Kd (38–40). But
the article of Shelley and Colquhoun (40) was later cor-
rected by them (41) and recent measurements do not support
Wang et al. (38) or Chen and Auerbach (39) (and Purohit
and Auerbach, unpublished data). This pattern implies that
if there are nonlocal effects of mutations, they usually do
not extend significantly to the binding site or to the regions
of the pore that regulate conductance.
Third, the map of F is organized spatially in the AChR
(33). There is approximately a coarse-grained, decreasing
gradient in F (which is related to the free energy of the tran-
sition state) between the transmitter binding sites and the
gate. If mutations change the energy of the transition state
by a nonlocal process, then this map would not necessarily
show any spatial pattern whatsoever. The map of F is easier
to rationalize assuming local interactions and a few interme-
diate states between R and R*.
Fourth, in some cases the free energy consequence of
a mutation can be correlated with a local structural change.
One example is unnatural mutations of aP272, where the
shift in EC50, probably caused by a shift in E0, correlates
with the energy of a cis-trans backbone isomerization at
this position (22). Another is at aT422, where hydrogen
bonds with elements in the membrane appear to correlate
with the free energy change of mutations (42).
There is much less experimental evidence suggesting
nonlocal effects. To our knowledge, mutant cycle analyses
have not revealed a single case of significant energy
coupling for separated residues. Long-duration, sponta-
neous openings that were proposed to reflect nonlocal inter-
actions between the binding site loop C and aP272 (and
elsewhere) (43) can be accounted for by assuming only local
effects at the transmitter binding site (17,19). Certainly, the
high F-values of some residue in the N-terminal, aM2 cap
suggest there could be a nonlocal transfer of energy (24).
There are also many examples where there is little or no
correlation between the chemical nature of the side-chain
substitution and the degree of free energy change, but this
may be because local interactions are complex and involve
multiple residues, and there are compensating changes in
both enthalpy and entropy. Although the issue of local–
versus-nonlocal processes is not resolved definitively, the
preponderance of the available experimental evidence
suggests that most (but not all) of the free energy changes
associated with most side-chain substitutions reflect local
structural changes.
The limited evidence we have gained regarding enthalpy
changes suggests that heat exchange, too, is local. The
enthalpy mutant cycle analysis shows that DDH values
were approximately additive for aW149F and dV269L.
With regard to mutational influences on Kd, aY127E hasBiophysical Journal 100(4) 904–911
910 Gupta and Auerbachno effect on the enthalpy (or entropy) of the equilibrium
dissociation constant for agonists, and the enthalpy changes
for different agonists parallels that for free energy (16). With
regard to the transition state, the experimental slopes of
enthalpy rate-equilibrium plots are the same as F, and the
gradient in these along the long axis of the AChR appears
so far to be the same as that for F. However, we cannot
discern a clear relationship between aW149 side-chain
substitutions and the corresponding magnitude of the
enthalpy or entropy changes. In what follows, we make
the assumption that perturbations (mutations and agonists)
change both the enthalpy and entropy of the gating isomer-
ization mainly by local structural changes.
With this assumption, the map of enthalpy changes is one
of heat absorption and emission in AChR gating, residue-
by-residue. At each position of this map, the enthalpy
changes may be able to provide insight into the natures of
the bond perturbations that occur locally as part of the
global protein isomerization. Note that a map of enthalpy
should reflect more closely the differences in bond angles
and atomic positions, R versus R*, compared to the corre-
sponding map of free energy. When unambiguous, high-
resolution structures of R-and-R* AChRs are available, it
will be the DDH values, more than the DDG values, that
consolidate our understanding of the gating mechanism.
There was a good correspondence between DDG and
DDH for different agonists. For these perturbations, the
enthalpy changes were not offset by entropy changes. We
speculate that for these perturbations, local changes in
bonds are mainly responsible for the free energy change,
and, hence, that changes in water structure or protein struc-
tural dynamics are not significant. The enthalpy changes
associated with different agonists appear to arise from
differences in ligand binding, specifically to the high-
affinity, R* conformation (16).
Enthalpy changes for the aW149 mutant series were
complex.DDGzDDH for Ala and Thr, but therewere large,
compensating changes in entropy with the Phe and Asn
substitutions. The Arg mutation was intermediate. This
region of the protein is complex and exposed to solvent,
and we cannot speculate about specific structural changes
associated with these mutations. However, it is important to
note that the aW149 experiments were without ligands and
we expect that the patterns of enthalpy and entropy changes
caused by mutations will be different with agonist molecules
present in the transmitter binding sites. This informationmay
help identify which bonds are changing between low- and
high-affinity conformations of the binding site.
Between the binding site and the gate, we measured DDH
and DEa
b values for several amino acids. At aP272, Ser and
Ala but not Gly caused a large increase in the enthalpy of the
transition state relative to R*. This raises the possibility that
the transition state enthalpy change here is associated with
a strain or movement of the backbone. This hypothesis is
consistent with the observed pattern of EC50 changes conse-Biophysical Journal 100(4) 904–911quent to unnatural amino-acid proline substitutions of this
residue in 5HT3A receptors (22). The aG153S mutation
also showed a substantial increase in DEa
b. The average
DEa
b was >5 kcal/mol for the aP272S, aP272A, and
aG153S mutations. However, for aP265, DEa
b was smaller
and similar for Ser, Ala, and Gly. This pattern suggests that
backbone flexibility may serve to lower the transition state
enthalpy in aP272 and aG153 but not aP265.
At aY127, there were large compensating decreases in
entropy for Cys and Glu side chains relative to Tyr. The
wt amino acid may be able to adopt alternative rotamers
(11). If this behavior is inhibited by the mutations, the
consequent loss of this dynamic could possibly contribute
to the decrease in entropy here. This residue is likely
exposed to water, and this could be another source of the
entropy change.
For aE45, Leu and Arg mutations had only small effects
on DEa
b, which suggests that the gating enthalpy change
here is not associated with the disruption of a salt bridge,
which would be expected to produce a much greater
enthalpy change.
aC418W showed a large DEa
b. We speculate that
the þ3.6 kcal/mol enthalpy increase of the barrier arises
from to a gating movement of the large Trp side chain
through the lipid environment. Our results suggest that
enthalpy-changes both within the protein and between the
protein and the lipids can contribute to the overall enthalpy
change of the isomerization.
The pattern of enthalpy change with mutations of the gate
residue dV269 (M2–130) was complex. Ala greatly decreased
the net gating enthalpy, with only a partial compensation in
entropy. Hence, the equilibrium constant with this mutation
was cold-activated. This may perhaps be associated with
a loss of an unfavorable steric interaction present with the
larger wt side chain. Cys, however, increased the enthalpy
but with a nearly-equivalent entropy gain and Leu had only
a small effect on both enthalpy and entropy. Like the binding
site, this region of the protein is accessible to water and ions
and it is difficult to parse out specific structural events that
may be associated with interactions with these structural
elements from those associated with intraprotein bonds.
The polar mutation dL265T (M2–90) showed a large increase
in the barrier enthalpy. Previously (31) we proposed that the
gate region of the channel becomes hydrated in R*, and that
interactions of the 90 side chains with water molecules at the
gate cause large, favorable, and late energy changes in the
isomerization. The dL265T mutation could slow channel
closing by making the dewetting of the gate region more
energetically unfavorable.
These results show that maps of DDG and DDH for AChR
gating are not equivalent. If heat is dissipated close to the
site of mutation, then DDH values can be considered to
reflect local changes in chemical bonding. A more-complete
thermal map, along with atomic structures, may help to illu-
minate the AChR gating mechanism.
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